CalcMyPeptide
Khavinson BioregulatorAlso known as: Cartilage & Bone Extract Bioregulator, Musculoskeletal Cytomax

Sigumir

Sigumir stands as the foundational Cytomax natural bioregulator for total skeletal and articular regeneration. Comprising complex peptide fractions extracted from the pristine cartilage and bone matrix of young animals, it is heavily relied upon by performance athletes and anti-aging physicians alike. It operates to aggressively reverse the brutal progression of osteoarthritis, violently halt osteoporotic bone loss, and dynamically rebuild destroyed joint capsules without the need for synthetic intervention.

Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Low1 peer-reviewed citation

Quick Stats

Half-LifeMixture (variable)
Dose Range1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Vial SizesN/A (oral)
BioavailabilityOral capsules
Year Developed1980s

Scientific Data

Molecular Formula
Polypeptide extract (Cartilage & Bone tissue <10 kDa)
Molecular Weight
Mixture (<10 kDa)
PubChem ID

Mechanism of Action

Sigumir (A-4) is a Cytomax natural polypeptide extract from the cartilage and bone tissue of young calves, targeting human chondrocytes, osteoblasts, and synovial cells to restore the gene expression governing collagen matrix synthesis, proteoglycan production, and anti-inflammatory joint signaling. Osteoarthritis affects approximately 250 million people globally and is fundamentally a disease of cartilage degradation: chondrocytes (cartilage cells) progressively lose their ability to synthesize type II collagen and aggrecan (the proteoglycan that gives cartilage its compressive strength), while simultaneously upregulating matrix metalloproteinases (MMP-13, ADAMTS-5) that degrade the extracellular matrix.

Sigumir delivers short peptide signals (<10 kDa) from bovine cartilage and bone tissue. These peptides enter chondrocyte and osteoblast nuclei to reactivate age-silenced genes encoding: type II collagen (COL2A1), aggrecan (ACAN), SOX9 (the master transcription factor for chondrocyte differentiation), and anti-inflammatory cytokines (IL-1Ra, which directly blocks the cartilage-destructive IL-1β signaling). Unlike glucosamine/chondroitin supplementation (which provides building block substrates), Sigumir works at the transcription level — it tells chondrocytes to re-express the genes for building these molecules.

In Khavinson's protocol, Sigumir (A-4, cartilage/bone) is combined with Gotratix (A-18, skeletal muscle) and Bonomarlot (A-20, bone marrow) to create the complete locomotor system protocol addressing cartilage, muscle, and blood cell regeneration simultaneously.

Source: PMID: 15677927

Background & History

Sigumir is the cartilage and bone Cytomax extract — natural counterpart to synthetic Cartalax.

Research Use Cases

  • Joint health
  • Osteoarthritis
  • Osteoporosis support

Dosing Protocol

Typical Dose1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Half-Life~30 minutes (estimated)

Dosing Protocols

Mini-Course / General Preventive (1 box)

Dose
2 capsules (20 mg)
Frequency
Once daily for 10 days, 30 min before meals
Note: Standard Khavinson mini-course (20 caps). Repeat every 6 months. Best combined with Gotratix (A-18, muscle) for the complete joint-muscle unit support.

Full Monthly Course (Joint Pain / OA)

Dose
2 capsules (20 mg)
Frequency
Twice daily for 30 days (120 caps = 2× 60-cap boxes)
Note: Bi-annual 30-day courses for adults with osteoarthritis, joint pain, or significant cartilage loss. Core locomotor stack: Sigumir (A-4) + Gotratix (A-18) + Bonomarlot (A-20) per Khavinson locomotor system protocol.

Intensive / Joint Restoration Protocol

Dose
2 capsules (20 mg)
Frequency
Twice daily, repeated monthly as needed
Note: For advanced osteoarthritis, post-operative joint recovery, or significant cartilage loss confirmed on imaging. Physician supervision advised. Max: 4 caps/day (40 mg).

Administration

Route
Oral capsules (20-cap and 60-cap boxes)
Timing
30 minutes before meals. Morning + evening for intensive courses.
Fasting Required?
Yes — inject on an empty stomach

Expected Timeline

Days 1—30
Chondrocyte gene expression restoration initiated. Some users report reduced morning joint stiffness within the first 2–4 weeks.
Month 1–3
Improved joint mobility and reduced inflammatory joint pain. Better cartilage matrix maintenance.
Month 3–6
Sustained cartilage integrity improvement. Reduced rate of cartilage degradation markers in studied populations.

Who Is It For?

Osteoarthritis / Joint Health (Ages 45+)

Low

Restores chondrocyte and osteoblast gene expression at the transcription level rather than just providing building block supplements like glucosamine.

Athletic Joint Preservation

Low

For high-load athletes seeking to slow cartilage wear. Best combined with Gotratix for complete joint-muscle support.

Safety & Considerations

Natural glandular extract (Cytomax) from bovine cartilage and bone tissue, <10 kDa. No hormones. Meets European/Russian veterinary standards. Generally recognized as safe.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Interactions & Contraindications

Standard Cytomax capsule protocol.

Synergies & Common Stacks

Sigumir (Cytomax) + Cartalax (synthetic) = comprehensive musculoskeletal bioregulator protocol.

Dosing Quick Reference

Sigumir— Dosing Guide
Dose Range
1-2 capsules/day
Half-Life
~30 minutes (estimated)
Frequency
1-2× daily for 10-30 day cycles
Route
Oral
Khavinson Bioregulatorcalcmypeptide.com

Frequently Asked Questions

How is Sigumir different from glucosamine/chondroitin?
Glucosamine and chondroitin provide substrate materials for cartilage matrix. Sigumir works at the gene expression level — it reactivates the transcription of COL2A1 (type II collagen gene) and SOX9 (chondrocyte differentiation master factor) in your existing chondrocytes, so the cells make more of their own matrix components.
What is the best stack for joints?
The Khavinson locomotor system protocol: Sigumir (A-4, cartilage/bone) + Gotratix (A-18, skeletal muscle) + Bonomarlot (A-20, bone marrow). This addresses every major component of the movement system — cartilage, muscle, and blood cell/immune support.

References

  1. Khavinson VKh "Peptide bioregulators — a new class of geroprotectors".” Bulletin of Experimental Biology and Medicine (2002). PMID: 12677266

📚 Related Articles

Recommended SourceOral Bioregulator

Get Sigumir from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.

Affiliate link · Full review